As a Cannabis industry medical practice, we would like to update our patients on the current recommendations from the Centers of Disease Control and Prevention and the FDA regarding the issue of severe lung illness related to vaping. As of this date, there have been approximately 450 cases reported in multiple states, including Florida. There have been 5 deaths reported. To date no definitive source of the illness has been determined. It has occurred in people vaping e-cigarettes or other vaping devices containing nicotine, substances extracted from cannabis (THC, CBD), or both.
Although not definitive, cases related to cannabis appear to be more common in
products bought from the internet black market or unlicensed
distributors. One of the most common ingredients in samples from sick
patients is Vitamin E acetate, which is a non-approved substance per Florida
guidelines for dispensaries. At this time, there is no
recommendation to avoid vape products sold in our licensed state dispensaries.
include coughing, fatigue and shortness of breath in anyone who has vaped
within the last 90 days. If you develop any of these symptoms, we urge
you to report this to us, as well as your primary care doctor.
Food and Drug
“Because consumers cannot be sure whether any THC vaping products may contain
vitamin E acetate, consumers are urged to avoid buying vaping products on the
street, and to refrain from using THC oil or modifying/adding any substances to
products purchased in stores”.
Centers for Disease
Control and Prevention statement includes these recommendations:
While this investigation is ongoing, consider not using e-cigarette products
Youth and young adults should not use e-cigarette products.
Women who are pregnant should not use e-cigarette products.
If you do use e-cigarette products, you should not buy these products off the
street (for example, e-cigarette products with THC or other cannabinoids).
You should not modify e-cigarette products or add any substances to these
products that are not intended by the manufacturer.
We will continue to closely monitor and update our patients as needed.
Mitchell N Davis, DO, FACOI, FACG
Chief Medical Officer, ComCan Healthcare, LLC